12.88 USD
+0.18 (+1.42%)
12.8801 USD
0 (0%)
Overall TRT gets a fundamental rating of 3 out of 10. We evaluated TRT against 113 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of TRT is average, but there are quite some concerns on its profitability. TRT has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
TRT had negative earnings in the past year.
In the past year TRT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: TRT reported negative net income in multiple years.
In the past 5 years TRT always reported a positive cash flow from operatings.
1.2 Ratios
TRT has a Return On Assets (-0.10%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -0.12%, TRT is in line with its industry, outperforming 46.90% of the companies in the same industry.
TRT has a Return On Invested Capital (0.34%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for TRT is significantly below the industry average of 10.77%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.1% | ||
| ROE | -0.12% | ||
| ROIC | 0.34% |
ROA(3y)2.01%
ROA(5y)2%
ROE(3y)2.82%
ROE(5y)2.96%
ROIC(3y)2.81%
ROIC(5y)N/A
1.3 Margins
The Operating Margin of TRT (0.42%) is comparable to the rest of the industry.
TRT's Operating Margin has declined in the last couple of years.
The Gross Margin of TRT (25.07%) is worse than 75.22% of its industry peers.
In the last couple of years the Gross Margin of TRT has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.42% | ||
| PM (TTM) | N/A | ||
| GM | 25.07% |
OM growth 3Y-57.25%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.98%
GM growth 5Y3.52%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TRT is destroying value.
The number of shares outstanding for TRT has been increased compared to 1 year ago.
TRT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, TRT has an improved debt to assets ratio.
2.2 Solvency
TRT has an Altman-Z score of 6.82. This indicates that TRT is financially healthy and has little risk of bankruptcy at the moment.
TRT has a better Altman-Z score (6.82) than 64.60% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that TRT is not too dependend on debt financing.
The Debt to Equity ratio of TRT (0.02) is better than 68.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.82 |
ROIC/WACC0.03
WACC10.69%
2.3 Liquidity
A Current Ratio of 5.03 indicates that TRT has no problem at all paying its short term obligations.
With a decent Current ratio value of 5.03, TRT is doing good in the industry, outperforming 73.45% of the companies in the same industry.
TRT has a Quick Ratio of 4.67. This indicates that TRT is financially healthy and has no problem in meeting its short term obligations.
TRT has a Quick ratio of 4.67. This is in the better half of the industry: TRT outperforms 77.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.03 | ||
| Quick Ratio | 4.67 |
3. Growth
3.1 Past
The earnings per share for TRT have decreased strongly by -105.27% in the last year.
The Revenue for TRT has decreased by -13.81% in the past year. This is quite bad
Measured over the past years, TRT shows a small growth in Revenue. The Revenue has been growing by 1.14% on average per year.
EPS 1Y (TTM)-105.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.71%
Revenue 1Y (TTM)-13.81%
Revenue growth 3Y-6.11%
Revenue growth 5Y1.14%
Sales Q2Q%9.49%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
TRT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TRT is valued cheaper than 88.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 11.83 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
TRT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
12.88
+0.18 (+1.42%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners23.91%
Inst Owner Change-0.09%
Ins Owners25.8%
Ins Owner Change1.77%
Market Cap56.03M
Revenue(TTM)36.47M
Net Income(TTM)-41.00K
Analysts0
Price TargetN/A
Short Float %0.36%
Short Ratio0.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.54 | ||
| P/FCF | N/A | ||
| P/OCF | 151.02 | ||
| P/B | 1.65 | ||
| P/tB | 1.65 | ||
| EV/EBITDA | 11.83 |
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.09
OCFY0.66%
SpS8.38
BVpS7.82
TBVpS7.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.1% | ||
| ROE | -0.12% | ||
| ROCE | 0.44% | ||
| ROIC | 0.34% | ||
| ROICexc | 0.66% | ||
| ROICexgc | 0.66% | ||
| OM | 0.42% | ||
| PM (TTM) | N/A | ||
| GM | 25.07% | ||
| FCFM | N/A |
ROA(3y)2.01%
ROA(5y)2%
ROE(3y)2.82%
ROE(5y)2.96%
ROIC(3y)2.81%
ROIC(5y)N/A
ROICexc(3y)5.18%
ROICexc(5y)N/A
ROICexgc(3y)5.18%
ROICexgc(5y)N/A
ROCE(3y)3.55%
ROCE(5y)N/A
ROICexgc growth 3Y-59.08%
ROICexgc growth 5YN/A
ROICexc growth 3Y-59.08%
ROICexc growth 5YN/A
OM growth 3Y-57.25%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.98%
GM growth 5Y3.52%
F-Score4
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.2 | ||
| Cap/Depr | 35.28% | ||
| Cap/Sales | 2.65% | ||
| Interest Coverage | 3.3 | ||
| Cash Conversion | 12.82% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.03 | ||
| Quick Ratio | 4.67 | ||
| Altman-Z | 6.82 |
F-Score4
WACC10.69%
ROIC/WACC0.03
Cap/Depr(3y)45.5%
Cap/Depr(5y)44.1%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-105.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.81%
Revenue growth 3Y-6.11%
Revenue growth 5Y1.14%
Sales Q2Q%9.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-86.65%
EBIT growth 3Y-59.86%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-127.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.35%
OCF growth 3Y-44.07%
OCF growth 5Y-34.21%
TRIO-TECH INTERNATIONAL / TRT FAQ
Can you provide the ChartMill fundamental rating for TRIO-TECH INTERNATIONAL?
ChartMill assigns a fundamental rating of 3 / 10 to TRT.
What is the valuation status of TRIO-TECH INTERNATIONAL (TRT) stock?
ChartMill assigns a valuation rating of 1 / 10 to TRIO-TECH INTERNATIONAL (TRT). This can be considered as Overvalued.
What is the profitability of TRT stock?
TRIO-TECH INTERNATIONAL (TRT) has a profitability rating of 3 / 10.